Loading the player...
Update on Emerging Infectious Diseases (COVID, Monkey Pox, Influenza)
Emerging infections are often new pathogens or variations of older pathogens and can cause new diseases. It is critical for physicians to understand the impact and importance for their patients and treatment options for these diseases.
Learning Objectives
Following the completion of this lecture, the participant will be able to:
Robert S. Jones, DO, MS, FACP, FIDSA, CPE is the medical director for Infectious Diseases and an associate medical director at the Quest Chantilly, Virginia lab. Dr Jones is a physician executive and healthcare leader with more than 20 years of experience in administration, clinical service line development, and performance improvement.
Dr. Jones earned his DO at the Philadelphia College of Osteopathic Medicine and completed his internal medicine residency at The Wright Center, followed by an infectious diseases fellowship at the Temple University Health Sciences Center.
Dr. Jones has led over 40 sponsored clinical trials centered around antibiotics, antivirals, and vaccines across multiple phases, and has authored over 50 papers and abstracts. His current primary research focuses on candida infections.
Dr Jones is board certified in infectious diseases by the American Board of Internal Medicine. He is a member of numerous professional societies, including the American College of Physicians, Society for Healthcare Epidemiology of America, Infectious Disease Society of America, Virginia Osteopathic Medical Association, and American Society of Microbiology.
Disclosures: Employed by Quest Diagnostics
